Candida test breakthrough for Rockeby Biomed
17 April, 2002 by Melissa TrudingerClinical trials have validated the efficacy of a new test kit for diagnosis of systemic candidiasis, developed by Perth company Rockeby Biomed.
Peptech ditches CEO hunt
16 April, 2002 by Daniella GoldbergPeptech's worldwide hunt for a new CEO has been abandoned after three of the board members, including its Chairman Dr Ed Tweddell, walked out of the company last week under pressure from angry shareholders.
GTG reaches agreement with Nanogen
16 April, 2002 by Melissa TrudingerGenetic Technologies has announced a licence agreement with Nanogen, following the company's agreement last week with US company Sequenom.
UNSW launches misconduct probe
16 April, 2002 by Daniella GoldbergA senior immunologist and kidney specialist has been accused of committing serious scientific misconduct and misspending public funds from the National Health and Medical Research Council.
Centre of Excellence race: and then there were four
15 April, 2002 by Tanya HollisApplicants for the Federal government's Biotechnology Centre of Excellence were today whittled down to four.
Dr Tom Schneider: Wake up and smell the apple pie: we need the US
15 April, 2002 by Tanya HollisBarely a week goes by when an overseas business expert isn't out here telling Australian companies how it should be done.
New reactor to boost medical research: ANSTO
15 April, 2002 by Daniella GoldbergThe new nuclear reactor at Lucas Heights, in Sydney, will give Australian medical researchers access to the latest therapeutic radioisotopes, according to the head of the facility's radioisotope manufacturing arm.
Support for NSW start-ups
15 April, 2002 by Daniella GoldbergStart-up biotechnology companies in NSW are to receive support through a new $2.5 million project.
Macquarie Bank to advise on synchrotron
12 April, 2002 by Tanya HollisMacquarie Bank has been appointed as financial adviser to the Victorian government's $157 million synchrotron project.
Lawyers push for new agency to keep up with science
12 April, 2002 by Pete YoungThe Australian Law Reform Commission may recommend the Howard government create an Australian equivalent of the UK Human Genetics Commission.
Investment company seeks to invest $50 million in biotech
11 April, 2002 by Daniella GoldbergAustralian Technology Innovations Fund (ATIF), a Brisbane-based private investment company, is seeking to invest $50 million in biotechnology projects and companies.
Progen scores half-million manufacturing deal
11 April, 2002 by Pete YoungUS biotech Lipid Sciences has signed a $500,000 manufacturing pact with Progen Industries, boosting Progen's already-thriving contract drug manufacturing arm.
Qld government moves to shore up R&D framework
11 April, 2002 by Pete YoungQueensland's Cabinet has kicked off a sweeping effort to set in place a long-term R&D framework in place for emerging industries.
Vita Life goes after former MD
11 April, 2002 by Tanya HollisVita Life Sciences is seeking recompense from its former managing director over what it says was a costly breach of agreement.
Chairman, board members resign from Peptech
11 April, 2002 by Daniella GoldbergThe three newest members of the board of Sydney biotech Peptech have resigned, after shareholders threatened to call an extraordinary general meeting to have them removed.
